Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia
Explore this paper's citation graph
Summary
Aspiration pneumonia, concomitant neoplasia, and neurological disease were factors positively associated with failure to improve, whereas monocytosis was linked to a better prognosis.
- Type
- article
- Published
- 2006-03-10
- Cited by
- 49
- References
- 36
- OpenAlex
- https://openalex.org/W16528540
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8916874
Keywords
Philosophy
References
- Mononuclear Phagocytes in Cell Biology
- Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
- Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications.
- Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
- Significance of Monocytosis in Varicella and Herpes Zoster
- Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
- Community-acquired pneumonia
- Severe community-acquired pneumonia. Epidemiology and prognostic factors.
- Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.
- Human monocytopoiesis in acute and chronic inflammation.
- Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.
- Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.
- Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.
- Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.
- The cost of treating community-acquired pneumonia.
- Influence of age on symptoms at presentation in patients with community-acquired pneumonia.
- Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.
- Cytomegalovirus infection in previously healthy adults.
- Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Cited by
- Community-acquired pneumonia in adult patients with special reference to rapid methods for etiological diagnosis
- Health promotion, risk stratification, and treatment options to decrease hospitalization rates for community‐acquired pneumonia in adults
- Removal of oesophageal foreign bodies: comparison between oesophagoscopy and oesophagotomy in 39 dogs.
- Guidelines for the management of adult lower respiratory tract infections--summary.
- Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia
- C-reactive protein for discriminating treatment failure from slow responding pneumonia.
- Evaluation of a rapid test for the diagnosis of pneumococcal pneumonia.
- Brazilian guidelines for community-acquired pneumonia in immunocompetent adults - 2009.
- Clinical scoring tools: which is best to predict clinical response and long-term outcomes?
- Clinical, clinicopathologic, and radiographic findings in dogs with aspiration pneumonia: 88 cases (2004-2006).
- Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality
- Guidelines for the management of adult lower respiratory tract infections - Full version
- Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality
- Oral antibiotics prior to hospitalisation for community-acquired pneumonia
- Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.
- SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009
- Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis
- At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.
- Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia.
Related papers
No related papers recorded.